Brief: Taysha Gene Therapies Announces Pricing Of Initial Public Offering
24/09/2020 12:05
Sept 24 (Reuters) - Taysha Gene Therapies Inc TSHA.O :
* TAYSHA GENE THERAPIES ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* TAYSHA GENE - ANNOUNCED PRICING OF ITS INITIAL PUBLIC
OFFERING
OF 7.9 MILLION SHARES OF COMMON STOCK AT PRICE OF $20.00 PER
SHARE
Source text for Eikon: ID:nBw5cZQpwa
Further company coverage: TSHA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taysha Gene Therapies
See all newsUniqure jumps after FDA vaccines chief Vinay Prasad to step down
US FDA names agency critic Vinay Prasad as top vaccine official (updated)
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
Gene therapy and vaccine makers fall after FDA names Vinay Prasad as top vaccine official
US FDA names oncologist Vinay Prasad as top vaccine official (updated)